Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-12-048468
Filing Date
2012-08-28
Accepted
2012-08-28 17:30:29
Documents
1
Group Members
MICHAEL S. WEISS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A v322520_sc13d-a.htm SC 13D/A 49498
  Complete submission text file 0001144204-12-048468.txt   51315
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Subject) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-51051 | Film No.: 121060874
SIC: 2834 Pharmaceutical Preparations

Mailing Address 787 7TH AVENUE 48TH FLOOR NEW YORK NY 10019
Business Address 787 7TH AVENUE 48TH FLOOR NEW YORK NY 10019 212-554-4504
Opus Point Partners, LLC (Filed by) CIK: 0001503454 (see all company filings)

EIN.: 262737756 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A